We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

OptiBiotix Health inks manufacturing deal with KAG Industries

Tue 30 April 2024 16:55 | A A A

No recommendation

No news or research item is a personal recommendation to deal. Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views.

(Sharecast News) - Life sciences company OptiBiotix Health announced on Tuesday that its its Indian subsidiary, OptiBiotix Health India (OHI), has entered into a manufacturing agreement with KAG Industries for the supply of 'Slimbiome' products tailored for the Indian market.

The AIM-traded firm said KAG, a specialised contract manufacturer of nutritional powders with its own research and development facilities, had crafted five unique flavours specifically designed for the Indian consumer.

It said the products would be marketed by OHI to Dr Morepen, a well-established brand in India dedicated to promoting customer health and well-being since 2001.

OptiBiotix said India represented a strategic market, with its population of 1.4 billion and a notable obesity prevalence of 40.3%.

The burgeoning middle-class population, expected to reach 475 million by 2030, presented a significant growth opportunity.

OptiBiotix said it was aiming to capitalise on that trend, particularly as India emerged as a dominant hub for global middle-class consumers by 2035.

"We are pleased to announce this agreement with KAG to support the launch of SlimBiome containing products with Dr Morepen, a well-known and trusted supplier to pharmacies, physicians, and retail customers across India," said chief executive officer Stephen O'Hara.

"We look forward to the upcoming launch of products across India with Dr Morepen and our manufacturing partners."

At 1630 BST, shares in OptiBiotix Health were up 5.8% at 18.25p.

Reporting by Josh White for Sharecast.com.

    The value of investments can go down in value as well as up, so you could get back less than you invest. It is therefore important that you understand the risks and commitments. This website is not personal advice based on your circumstances. So you can make informed decisions for yourself we aim to provide you with the best information, best service and best prices. If you are unsure about the suitability of an investment please contact us for advice.


    More AIM news from ShareCast

    No results were found